Fig. 2From: Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directionsStructure of lipid A and MPL from S. Minnesota R595. (A) structure of lipid of LPS from S. Minnesota R595. (B) structure of MPL hydrolyzed from (A)Back to article page